Three SPACs File SEC 8-Ks: Hudson, Nordic and Drugs Made In America Close Deals

The Quick Take

• Nordic Acquisition Corp filed 8-K on Sept 14 covering material agreement entry and completed asset acquisition
• Hudson Acquisition I Corp filed 8-K on Sept 14 for shareholder vote submission (Item 5.07)
• Drugs Made In America Acquisition Corp filed 8-K for material agreement and financial statements (Item 9.01)
• All three filings dated September 14, 2026, signal concurrent SPAC transaction pipeline activity

Three distinct special purpose acquisition companies filed Form 8-K disclosures on the same date, each at different stages of their transaction lifecycles. Nordic Acquisition Corp's combined Items 1.01 and 2.01 indicate both a definitive agreement signing and a completed asset acquisition, placing it at or near merger close. Hudson Acquisition I Corp's Item 5.07 addresses shareholder vote results, a procedural milestone in the merger approval process. Drugs Made In America Acquisition Corp's Items 1.01 and 9.01 indicate a material agreement entry with accompanying financial statements for the target company.

The simultaneous filing of multiple SPAC-related 8-Ks reflects continued activity in the blank-check company ecosystem despite broader cooling from the 2020-2021 SPAC peak. Each filing type indicates a different transaction phase: shareholder votes precede closings, material agreement filings mark definitive deal signing, and financial statement filings accompany target company disclosure. SPAC investors and arbitrageurs tracking these filings can extract deal timeline signals from the item types disclosed, with concurrent activity across three vehicles suggesting a broader pipeline of deals moving toward resolution.

Monitor target company disclosures embedded in each 8-K's exhibits for valuation, deal terms, and industry sector of the acquired businesses. Nordic Acquisition Corp's completion filing means its shares may be subject to redemption or conversion mechanics imminently. Hudson's shareholder vote results will indicate approval rates and redemption levels, key metrics for SPAC deal economics. The Drugs Made In America name signals a domestic pharmaceutical or biotech target; watch for subsequent press releases and analyst commentary on the target's commercial pipeline and revenue stage.

Synthesized from 3 sources.